Literature DB >> 24890344

Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.

Niina Matikainen1, Martin Adiels, Sanni Söderlund, Sanna Stennabb, Tytti Ahola, Antti Hakkarainen, Jan Borén, Marja-Riitta Taskinen.   

Abstract

OBJECTIVE: Postprandial hypertriglyceridemia is an important risk factor for cardiovascular disease. The mechanisms are still unclear. Here it was tested if hepatic de novo lipogenesis (DNL) and lipid oxidation influence the postprandial responses of triglyceride-rich lipoproteins (TRL) in humans.
METHODS: The contribution of hepatic DNL to hepatic TRL production was analyzed in 67 men and women with a moderate range of BMI after a fat-rich meal. Also, lipase activities, liver fat, and 3-OH-butyrate were quantitated as an indicator of β-oxidation. Lipoproteins and metabolic markers were measured in fasting and postprandial blood samples.
RESULTS: Postprandial DNL correlates with postprandial TG and apolipoprotein (apo) C-III responses in plasma and with TG, apoB48 and apoB100 responses in TRLs and their larger remnant particles. Fasting and 8-h postprandial DNL was inversely related to 3-OH-butyrate but not to liver fat content. Fasting apoC-III and 3-OH-butyrate, but not liver fat, independently predicted fasting DNL.
CONCLUSIONS: The fasting and 8-h postprandial rate of DNL was inversely associated with the hepatic lipid oxidation in humans. DNL contributes significantly to the TG content in TRLs but not to the amount of liver fat, suggesting that an imbalance between DNL and fat oxidation contributes to postprandial atherogenic dyslipidemia.
Copyright © 2014 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24890344     DOI: 10.1002/oby.20781

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  12 in total

1.  Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates.

Authors:  Andrew A Butler; Jinsong Zhang; Candice A Price; Joseph R Stevens; James L Graham; Kimber L Stanhope; Sarah King; Ronald M Krauss; Andrew A Bremer; Peter J Havel
Journal:  J Biol Chem       Date:  2019-04-15       Impact factor: 5.157

2.  Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism.

Authors:  Ilenia Minicocci; Anna Tikka; Eleonora Poggiogalle; Jari Metso; Anna Montali; Fabrizio Ceci; Giancarlo Labbadia; Mario Fontana; Alessia Di Costanzo; Marianna Maranghi; Aldo Rosano; Christian Ehnholm; Lorenzo Maria Donini; Matti Jauhiainen; Marcello Arca
Journal:  J Lipid Res       Date:  2016-04-03       Impact factor: 5.922

Review 3.  From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations.

Authors:  Charlotte J Green; Camilla Pramfalk; Karl J Morten; Leanne Hodson
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-28       Impact factor: 4.310

4.  Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women.

Authors:  Leanne Hodson; Rajarshi Banerjee; Belén Rial; Wiebke Arlt; Martin Adiels; Jan Boren; Kyriakoula Marinou; Ciaran Fisher; Ingrid L Mostad; Irene M Stratton; P Hugh R Barrett; Dick C Chan; Gerald F Watts; Karin Harnden; Fredrik Karpe; Barbara A Fielding
Journal:  J Am Heart Assoc       Date:  2015-10-02       Impact factor: 5.501

5.  A Single Day of Excessive Dietary Fat Intake Reduces Whole-Body Insulin Sensitivity: The Metabolic Consequence of Binge Eating.

Authors:  Siôn A Parry; Rachel M Woods; Leanne Hodson; Carl J Hulston
Journal:  Nutrients       Date:  2017-07-29       Impact factor: 5.717

Review 6.  Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis.

Authors:  Sergio Quesada-Vázquez; Gerard Aragonès; Josep M Del Bas; Xavier Escoté
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

7.  Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding.

Authors:  Wee Suan Low; Thomas Cornfield; Catriona A Charlton; Jeremy W Tomlinson; Leanne Hodson
Journal:  Nutrients       Date:  2018-09-07       Impact factor: 5.717

8.  Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study.

Authors:  Niina Matikainen; Sanni Söderlund; Elias Björnson; Kirsi Pietiläinen; Antti Hakkarainen; Nina Lundbom; Marja-Riitta Taskinen; Jan Borén
Journal:  Diabetes Obes Metab       Date:  2018-09-04       Impact factor: 6.577

9.  Liver fat storage pathways: methodologies and dietary effects.

Authors:  Kay H M Roumans; Jeremy Basset Sagarminaga; Harry P F Peters; Patrick Schrauwen; Vera B Schrauwen-Hinderling
Journal:  Curr Opin Lipidol       Date:  2021-02-01       Impact factor: 4.616

10.  Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans.

Authors:  Jan Borén; Martin Adiels; Elias Björnson; Niina Matikainen; Sanni Söderlund; Joel Rämö; Marcus Ståhlman; Pietari Ripatti; Samuli Ripatti; Aarno Palotie; Rosellina M Mancina; Antti Hakkarainen; Stefano Romeo; Chris J Packard; Marja-Riitta Taskinen
Journal:  JCI Insight       Date:  2020-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.